Literature DB >> 30131258

Respiratory tract infections in children with tracheostomy.

Chiew-Yin Tan1, Nan-Chang Chiu2, Kuo-Sheng Lee3, Hsin Chi4, Fu-Yuan Huang1, Daniel Tsung-Ning Huang1, Lung Chang5, Yen-Hsin Kung5, Ching-Ying Huang1.   

Abstract

BACKGROUND: Children with tracheostomy are at increased risk for respiratory tract infections, yet the risk involved in tracheostomy related infections is unclear.
METHODS: We conducted a retrospective review of the medical records of children who underwent tracheostomy between January 2002 and December 2016 at a teaching hospital in Taipei. Demographics, underlying disease, indication for tracheostomy, laboratory data and management, and long-term outcome data were collected. Infection episodes were grouped into definite, possible, non-bacterial pneumonia, and local infection groups.
RESULTS: Ninety patients were enrolled. Forty-two (46.7%) patients had infections that required hospitalization. Definite bacterial pneumonia accounted for 12 (8.5%) episodes, 113 episodes (80.1%) were possible bacterial pneumonia, 12 (8.5%) were non-bacterial pneumonia, and 4 (2.8%) were local infections. Patients with definite and possible bacterial pneumonia were found to have a longer hospital duration than patients with non-bacterial pneumonia (p=0.024), with mean hospitalization stays of 8.83±5.59 days and 5.67±2.55 days, respectively. The median duration from tracheostomy to bacterial pneumonia was 1.78 years (range, 0.04- 11.38) whereas for the non-bacterial pneumonia group it was 0.57 years (range, 0.04-6.61). Cerebral palsy (CP) (adjusted odds ratio [AOR] 3.65; 95% confidence interval [CI]: 1.11-11.99; p=0.033) and gastroesophageal reflux disease (GERD) (AOR 2.84; 95% CI: 1.09-7.38; p=0.033) were independently associated with respiratory tract infections in these children.
CONCLUSION: In this study, CP and GERD were associated with infections in children with tracheostomy. Bacterial and non-bacterial pneumonia are difficult to differentiate clinically which may lead to unnecessary antibiotics use.
Copyright © 2018. Published by Elsevier B.V.

Entities:  

Keywords:  Children; Respiratory tract infections; Tracheostomy

Year:  2018        PMID: 30131258     DOI: 10.1016/j.jmii.2018.07.002

Source DB:  PubMed          Journal:  J Microbiol Immunol Infect        ISSN: 1684-1182            Impact factor:   4.399


  6 in total

1.  Evaluation of the Treatment of Stenotrophomonas maltophilia in Tracheostomy-Dependent Pediatric Patients.

Authors:  Emma M Tillman; Sarah E Firmani; Veda L Ackerman; James E Slaven; A Ioana Cristea
Journal:  J Pediatr Pharmacol Ther       Date:  2019 Nov-Dec

2.  Performance of a multiplex PCR pneumonia panel for the identification of respiratory pathogens and the main determinants of resistance from the lower respiratory tract specimens of adult patients in intensive care units.

Authors:  Sze Hwei Lee; Sheng-Yuan Ruan; Sung-Ching Pan; Tai-Fen Lee; Jung-Yien Chien; Po-Ren Hsueh
Journal:  J Microbiol Immunol Infect       Date:  2019-11-23       Impact factor: 4.399

3.  Tracheostomy colonisation and microbiological isolates of patients in intensive care units-a retrospective study.

Authors:  Segana Hasan Abdul Cader; Fahim Ahmed Shah; S K G Reghunandanan Nair
Journal:  World J Otorhinolaryngol Head Neck Surg       Date:  2020-03-29

Review 4.  Current State of Respiratory Syncytial Virus Disease and Management.

Authors:  Archana Chatterjee; Kunjana Mavunda; Leonard R Krilov
Journal:  Infect Dis Ther       Date:  2021-03-03

5.  Lower Respiratory Tract Infections in Pediatric Patients with Severe Neurological Impairments: Clinical Observations and Perspectives in a Palliative Care Unit.

Authors:  Maximilian David Mauritz; Carola Hasan; Pia Schmidt; Arne Simon; Markus Knuf; Boris Zernikow
Journal:  Children (Basel)       Date:  2022-06-08

Review 6.  Diagnosis, management, and outcomes of pediatric tracheostomy-associated infections: A scoping review.

Authors:  John M Morrison; Amir Hassan; Lynn Kysh; Robert A Dudas; Christopher J Russell
Journal:  Pediatr Pulmonol       Date:  2022-03-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.